-
EP3850946
European procedure
Extract from the Register of European Patents
EP About this file: EP3850946
| EP3850946 - NICHTHUMANE TIERE MIT HUMANISIERTEM CLUSTER DES DIFFERENZIERUNGS-47-GENS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.08.2024 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 25.08.2023 | ||
| Former | Grant of patent is intended Status updated on 18.04.2023 | ||
| Former | Examination is in progress Status updated on 01.07.2022 | ||
| Former | Request for examination was made Status updated on 28.01.2022 | ||
| Former | The application has been published Status updated on 18.06.2021 | Most recent event Tooltip | 02.08.2024 | No opposition filed within time limit | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | [2021/29] | Inventor(s) | 01 /
GURER, Cagan c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 02 /
IOFFE, Ella c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 03 /
MUJICA, Alexander c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | 04 /
THURSTON, Gavin c/o Regeneron Pharmaceuticals, Inc 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 / US | [2021/29] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2023/39] |
| Former [2021/29] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 20215046.2 | 25.11.2015 | [2021/29] | Priority number, date | US201462087992P | 05.12.2014 Original published format: US 201462087992 P | [2021/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3850946 | Date: | 21.07.2021 | Language: | EN | [2021/29] | Type: | B1 Patent specification | No.: | EP3850946 | Date: | 27.09.2023 | Language: | EN | [2023/39] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.06.2021 | Classification | IPC: | A01K67/027, G01N33/50, C07K14/705, C07K16/28, A61P35/00, C07K14/47 | [2021/29] | CPC: |
A01K67/0278 (EP,CN,IL,KR,RU,US);
A61K49/0008 (CN,IL,RU);
A61P35/00 (EP,IL);
C07K14/4703 (EP,IL,US);
C07K14/705 (IL,US);
C07K14/70503 (CN,IL,US);
C07K14/70596 (EP,IL,KR,US);
C07K16/2803 (EP,IL,US);
C12N15/63 (US);
C12N15/8509 (IL,KR,RU,US);
G01N33/5011 (EP,IL,RU,US);
G01N33/5014 (EP,IL,RU,US);
G01N33/5055 (EP,IL,RU,US);
G01N33/5088 (EP,IL,KR,RU,US);
A01K2207/12 (IL,US);
A01K2207/15 (EP,CN,IL,KR,US);
A01K2217/05 (CN,IL);
A01K2217/052 (IL,KR,US);
A01K2217/072 (EP,IL,KR,US);
A01K2217/15 (EP,IL,KR,US);
A01K2227/105 (EP,CN,IL,KR,US);
A01K2267/03 (CN,IL);
A01K2267/0331 (EP,IL,KR,US);
A01K2267/0381 (EP,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/09] |
| Former [2021/29] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | NICHTHUMANE TIERE MIT HUMANISIERTEM CLUSTER DES DIFFERENZIERUNGS-47-GENS | [2021/29] | English: | NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE | [2021/29] | French: | ANIMAUX NON HUMAINS AYANT UN GROUPE HUMANISÉ DE GÈNE DE DIFFÉRENCIATION 47 | [2021/29] | Examination procedure | 20.01.2022 | Amendment by applicant (claims and/or description) | 20.01.2022 | Examination requested [2022/09] | 20.01.2022 | Date on which the examining division has become responsible | 01.07.2022 | Despatch of a communication from the examining division (Time limit: M04) | 24.10.2022 | Reply to a communication from the examining division | 19.04.2023 | Communication of intention to grant the patent | 18.08.2023 | Fee for grant paid | 18.08.2023 | Fee for publishing/printing paid | 18.08.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP15813960.0 / EP3086637 | EP18207075.5 / EP3466255 | Divisional application(s) | EP23192469.7 / EP4296278 | Opposition(s) | 28.06.2024 | No opposition filed within time limit [2024/36] | Fees paid | Renewal fee | 17.12.2020 | Renewal fee patent year 03 | 17.12.2020 | Renewal fee patent year 04 | 17.12.2020 | Renewal fee patent year 05 | 17.12.2020 | Renewal fee patent year 06 | 18.11.2021 | Renewal fee patent year 07 | 22.11.2022 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2007033221 (GEN HOSPITAL CORP [US], et al); | [A]WO2013063556 (REGENERON PHARMA [US]); | by applicant | US5670356 | US5874304 | US6586251 | US7294754 | US2010051339 | US8354389 | US8518392 | US8697851 | WO2012US25040 | WO2012US62379 | WO2013US45788 | WO2013US58448 | WO2014US56910 | WO2014US60568 | WO2014US64806 | WO2014US64810 |